SternEnzym specializes in the development and application of functional enzyme systems for the food industry. The main applications include bread and fine pastries, sugar and specialty sugars, various dairy products, as well as fish and meat applications.

SternEnzym

Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. It has a strategic collaboration with UPL Ltd. to develop and commercialize microbial-based bio solutions for sustainable agriculture. The company was founded in 1843 and is headquartered in Hørsholm, Denmark.

Chr. Hansen Holding A/S

Connell Bros. Company, LTD is involved in the chemical industry, providing a platform for product indexing and information services in the field of chemistry. The site offers various synonyms for compounds and language options for users.

Connell Bros. Company, LTD

Aum Enzymes is a metabolic engineering firm specializing in microbial origin, industrial-grade enzymes produced by solid-state fermentation and submerged fermentation. Self-described as one of the top ten Food Enzymes manufacturers in the world.

Metric
Company Name	SternEnzym	Chr. Hansen Holding A/S	Connell Bros. Company, LTD	Aum Enzymes
Symbol		CHR
MSH ID	DE:STERNENZYM	COM:CHR-HANSEN	COM:GUIDECHEM:CONNELLBROTHERS	COM:AUMENZYMES
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Consumer Goods	Basic Materials	Commercial & Professional Services	Commercial & Professional Services
Industry	Food & Beverage	Chemicals - Specialty	Chemicals	Biotechnology
Country	DE	DK	CN	IN
Stage
Employee Count	11	3.83K	5.00K
Website	sternenzym.de	chr-hansen.com	connellbrothers.guidechem.com	aumenzymes.com
LinkedIn	sternenzym-enzymedesigner	chr-hansen-as		aumenzymes
Founders

Metric
Market Cap	10.24B
Enterprise Value
Monthly Web Traffic	36.84K	266
Web Traffic Growth	-0.48	7.68
Valuation
Raised Capital

Metric
Revenue		1.41B
Revenue (LTM)
Revenue (NTM)
Gross Profit		763.97M
EBITDA		499.28M
Operating Income		378.98M
Net Income		239.76M
EPS		1.82
Diluted EPS		1.82
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.54
Operating Profit Margin		0.26
EBITDA Margin		0.35
Net Profit Margin		0.17
Return on Equity		0.12
Return on Assets		0.07
Return on Capital Employed		0.11

STER

DE:STERNENZYM

SternEnzym

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		41.92
P/B Ratio		5.21
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		7.27
EV Multiple		25.10

Metric
Days Sales Outstanding
Days Payables Outstanding		62.19
Days Inventory Outstanding		115.99
Operating Cycle		173.22
Cash Conversion Cycle		106.62
Asset Turnover		0.39

Metric
Operating Cash Flow		334.72M
Free Cash Flow		211.99M
Cash Flow to Debt		0.34
Operating Cash Flow/Sales		0.24
Free Cash Flow Yield		0.02

Metric
Cash & Equivalents		59.15M
Accounts Receivable
Inventory		205.12M
Goodwill		1.59B
Debt to Capitalization		0.33
Debt to Assets		0.31
Current Ratio		1.67
Quick Ratio		0.73

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue		0.08
SG&A to Revenue		0.07